An amphiphilic dendrimer engineered nanocarrier system (ADENS) possessing a unique hollow core/shell structure is developed, in which siRNA is incorporated in the hydrophilic cavity and paclitaxel is abundantly depoted in the hydrophobic interlayer. Then, the ADENS is modified by tumor microenvironment-sensitive polypeptides (TMSP). The TMSP-ADENS shows enhanced cellular uptake, tumor penetration and accumulation in a MMP-2/9-triggered mechanism. The TMSP-ADENS provides a potential strategy for effective co-delivery of siRNA and paclitaxel for anti-tumor therapy in a synergistic manner.
- Xin Li
- A-ning Sun
- Xian-rong Qi
